Skip to content
MarketScale
‹ Back to IndustriesHealthcare

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · HfmaHealthcare Financial Management AssociationHospital FinanceRevenue Cycle Management
Share
Learn this in 60 seconds

Key facts, context, and what it means, in one minute.

:60
0:001:00
HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

Key takeaways

01

HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.

02

Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.

03

HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

HFMA put a hospital CFO in the chair as Medicare reporting gets more granular and revenue cycle operations get more technical.

In a June 8, 2026 announcement carried by GlobeNewswire, the Healthcare Financial Management Association said Matthew E. Cox, executive vice president and CFO of Corewell Health, assumed the role of national chair, effective June 1, 2026. HFMA also named new officers and board members whose day jobs sit directly on the levers hospitals pull hardest right now: reimbursement interpretation, cost reporting execution, and revenue cycle throughput.

For hospital operators, the signal is less about association governance and more about what the governance reflects. The work is shifting from “close the books and file the reports” to “produce auditable, line-item-ready data that survives payer scrutiny and CMS methodology changes without grinding operations to a halt.”

The board roster mirrors where the operational load is landing

HFMA’s chair role moving to a system CFO is notable because the board slate also emphasizes revenue cycle and reimbursement execution. GlobeNewswire reported that Michele Napier, senior vice president and chief revenue officer for Orlando Health, joined HFMA’s board, and that her scope covers $7 billion in patient revenue spread across 21 hospitals and 3,500 physicians and clinicians. That scale is a useful reference point: in organizations that large, minor tweaks to prior auth steps, coding edits, or claim status workflows can quickly become meaningful cash timing and staffing problems.

The same release listed other leaders with direct line-of-sight into how finance strategy becomes operating reality, including BJC Health System CFO Scott R. Hawig as secretary-treasurer and SSM Health CFO Kevin Smith as a newly elected board member. GlobeNewswire also noted the election of Ash Shehata, managing director at Impact Advisors, who previously served as U.S. healthcare leader at KPMG.

Every new CMS worksheet is a policy change that turns into a data-integration project.

CMS cost reporting is turning into a data pipeline problem

HFMA’s own policy coverage points to why the association is elevating leaders who live in the messy middle between regulation and workflow. HFMA reported that Medicare Worksheet S-12 adds to hospital cost-reporting demands, an example of how cost report preparation keeps expanding in scope and detail.

Separately, HFMA published a summary of CMS’s FY 2027 IPPS/LTCH PPS final rule (dated August 19, 2026). Even when the policy changes are understood quickly, the operational bottleneck is often evidence: where the data comes from, how it’s normalized across facilities, and whether internal definitions match CMS expectations well enough to avoid rework later.

This is where finance ops and IT ops meet in the hallway. Cost reporting teams increasingly need repeatable extraction logic from the EHR, the general ledger, and ancillary systems, plus governance for mappings and version control. If a system is still rebuilding the cost report from scratch each year, Worksheet changes tend to trigger fire drills.

Credentialing is becoming a capacity strategy, not a resume line

HFMA’s certification catalog reads like a map of the roles hospitals are trying to stabilize. On its certifications page, HFMA lists the Certified Hospital Cost Report Specialist (CHCRS), the Certified Revenue Cycle Representative (CRCR), and the Certified Specialist Payment & Reimbursement (CSPR), among others, with associated continuing education credits.

Hospitals have long trained these skills internally, but the push toward formal credentials suggests a capacity problem: teams need a common baseline for reimbursement concepts, documentation standards, and analytics methods that span facilities and acquired physician groups. Credentials also make it easier to standardize job ladders across shared services, especially when revenue cycle functions are split between system and site.

Hospitals aren’t just hiring billers. They’re staffing for defensible reimbursement in a world of finer-grained reporting.

There is also a practical procurement angle. Systems buying revenue cycle tools, cost accounting platforms, or managed care analytics often discover they are also buying internal change management. A more credentialed workforce can shorten implementation timelines because requirements gathering, testing, and exception handling get better inputs.

Where this lands in 2026 operating plans

The most immediate implication is workload planning. When HFMA flags Worksheet S-12 as an added cost-reporting demand, it indicates that hospitals should expect more cross-departmental data requests and more iterative validation cycles. That tends to hit decision-makers responsible for shared services staffing, data governance, and audit readiness.

It also raises an execution question for multi-hospital systems: whether cost reporting and reimbursement policy interpretation are centralized with strong tooling, or distributed with local workarounds. Centralization can improve consistency, but only if underlying source systems and master data are mature enough to support it.

Questions to put in front of finance ops and IT before the next cost report cycle

  • Where, exactly, is the source of truth for cost-report inputs (GL, EHR, cost accounting, decision support), and who owns the mappings that feed Medicare worksheets such as S-12, per HFMA’s reporting on added demands?
  • Does the cost report process run as a repeatable pipeline with versioned extracts and reconciliations, or as a one-off project that depends on a few people and spreadsheets?
  • Which roles are credentialed today (CHCRS, CRCR, CSPR), and does that match where internal rework is happening: reimbursement interpretation, documentation, claim edits, or payer contract analytics, per HFMA’s certification catalog?
  • If new CMS IPPS/LTCH PPS final rule changes alter assumptions mid-year, how quickly can finance and IT rerun the downstream reporting logic without disrupting close processes, per HFMA’s FY 2027 final rule summary coverage?

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Interchangeable biosimilars cut drug spend only when pharmacies can actually switch them

Interchangeable biosimilars cut drug spend only when pharmacies can actually switch them

The FDA’s interchangeable biosimilar pathway is moving from a one-off insulin milestone to a repeatable playbook for pharmacy-level substitution, with Wezlana (ustekinumab-auub) approved as interchangeable to Stelara in late 2023 and a first interchangeable biosimilar to golimumab reported in September 2026. Evidence from a JAMA Health Forum economic evaluation cited by Podiatry Today found that insulin glargine interchangeability in November 2021 was followed by an immediate jump of more than 47,000 prescriptions for Semglee and insulin glargine-yfgn, suggesting the designation itself can change dispensing behavior. For hospitals, health systems, and payers, the operational consequence shows up less in the FDA letter and more in formulary design, NDC-level claims logic, pharmacy notification requirements that vary by state, and the inventory and education workflows that make substitution predictable instead of chaotic.

  • 01Interchangeability is a workflow change, not a clinical debate. The systems that decide spend are NDC mapping, e-prescribe defaults, and pharmacy switch rules governed by state law.
  • 02The pipeline is widening beyond diabetes. Wezlana’s interchangeability to Stelara (Healthcare Purchasing News) and a newly reported interchangeable golimumab biosimilar (Journal of Healthcare Management/AJN via Ovid) signal more specialty and infusion-adjacent categories will face pharmacy-level substitution decisions.

Sep 2, 2026

More nurses did not lift safety culture scores in a 205-hospital analysis

More nurses did not lift safety culture scores in a 205-hospital analysis

A 2026 analysis in the Journal of Hospital Management and Health Policy combined 2021–2022 HSOPC results with AHA, HCRIS, and AHRF data across 205 hospitals and reported that small increases in nurse and physician staffing lined up with slightly lower “percent positive” patient safety culture scores in several dimensions. According to the Journal of Healthcare Management abstract hosted on Ovid, the study described a 2% decrease in positive staffing perceptions with β=−0.02 per additional nurse FTE and a −0.01 change in perceived reporting of patient safety events per additional nurse, while additional physician staffing was associated with −0.01 changes in perceptions of communication openness and organizational learning, and joint ventures were associated with a −0.03 change in perceptions of management support for safety (all p<0.05). The operational read is that adding headcount by itself does not ensure stronger safety-culture signals; hospitals also need the workflows that turn observations into closed-loop fixes, from “just culture” reporting expectations to facilities work-order follow-through, as described by Sentara Health leaders in Chief Healthcare Executive and by Health Facilities Management’s environment-of-care guidance. For health system operators, the near-term consequence shows up in how HSOPC survey targets connect to leader scorecards, rounding programs, digital reporting tools, and joint-venture governance, especially where staffing growth is driven by complexity and handoffs.

  • 01If HSOPC “percent positive” scores are a board KPI, staffing increases can move in the opposite direction unless reporting and learning loops scale too. The study’s negative coefficients are small, but they signal a measurement risk during growth.
  • 02Facilities and clinical safety cultures converge in the same pipeline: observation, reporting, triage, work order, verification. HFM Magazine’s door-lock example is the same system problem as event reporting, it is throughput and closure, not awareness.
  • 03Joint ventures can add operational complexity that dilutes perceived management support for safety. That belongs in JV governance charters and integration playbooks, not only in finance models.

Sep 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512